Bob Siegerink

5.5k total citations · 1 hit paper
94 papers, 2.9k citations indexed

About

Bob Siegerink is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Neurology. According to data from OpenAlex, Bob Siegerink has authored 94 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 23 papers in Cardiology and Cardiovascular Medicine and 16 papers in Neurology. Recurrent topics in Bob Siegerink's work include Acute Ischemic Stroke Management (28 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Blood Coagulation and Thrombosis Mechanisms (13 papers). Bob Siegerink is often cited by papers focused on Acute Ischemic Stroke Management (28 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Blood Coagulation and Thrombosis Mechanisms (13 papers). Bob Siegerink collaborates with scholars based in Germany, Netherlands and United States. Bob Siegerink's co-authors include Ale Algra, Frits R. Rosendaal, Matthias Endres, Frederikus A. Klok, Stefano Barco, Philip G. de Groot, Carmine Zoccali, Friedo W. Dekker, Kitty J. Jager and Rolf T. Urbanus and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bob Siegerink

87 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19

2020 394 citations Frederikus A. Klok, Gudula J.A.M. Boon et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bob Siegerink Germany	30	626	620	589	485	401	94	2.9k
Christel Renoux Canada	30	632 1.0×	331 0.5×	842 1.4×	269 0.6×	266 0.7×	117	3.7k
Laura M. Dember United States	40	392 0.6×	634 1.0×	465 0.8×	672 1.4×	1.3k 3.3×	122	6.3k
Jacob Elkins United States	30	725 1.2×	1.2k 1.9×	562 1.0×	154 0.3×	700 1.7×	75	3.3k
Ralf Junker Germany	37	615 1.0×	730 1.2×	1.1k 1.8×	1.9k 3.9×	479 1.2×	93	4.7k
Maria García-Gil Spain	33	715 1.1×	1.4k 2.2×	709 1.2×	109 0.2×	535 1.3×	110	4.2k
Y. van der Graaf Netherlands	37	787 1.3×	696 1.1×	551 0.9×	131 0.3×	671 1.7×	84	3.9k
Ellen S. O’Meara United States	35	263 0.4×	484 0.8×	560 1.0×	190 0.4×	713 1.8×	78	3.8k
Armin Grau Germany	37	1.2k 1.9×	2.3k 3.8×	963 1.6×	333 0.7×	1.2k 3.1×	136	5.5k
Lauralyn McIntyre Canada	43	689 1.1×	1.3k 2.2×	731 1.2×	473 1.0×	1.1k 2.8×	156	7.2k
Dóra Körmendiné Farkas Denmark	27	116 0.2×	474 0.8×	402 0.7×	283 0.6×	267 0.7×	125	2.4k

Countries citing papers authored by Bob Siegerink

Since Specialization

Citations

This map shows the geographic impact of Bob Siegerink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob Siegerink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob Siegerink more than expected).

Fields of papers citing papers by Bob Siegerink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bob Siegerink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob Siegerink. The network helps show where Bob Siegerink may publish in the future.

Co-authorship network of co-authors of Bob Siegerink

This figure shows the co-authorship network connecting the top 25 collaborators of Bob Siegerink. A scholar is included among the top collaborators of Bob Siegerink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bob Siegerink. Bob Siegerink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goerling, Ute, et al.. (2025). Difficulties in Care and Unmet Needs from the Perspective of Patients with Lung Cancer and Stroke – A Qualitative Study in Germany. Patient Preference and Adherence. Volume 19. 791–804.

Kort, Anna M. de, Bob Siegerink, Sabine Voigt, et al.. (2024). Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy. Alzheimer s Research & Therapy. 16(1). 74–74. 3 indexed citations

Etten, Ellis S. van, Bob Siegerink, L. Jaap Kappelle, et al.. (2023). Iatrogenic Cerebral Amyloid Angiopathy Post Neurosurgery: Frequency, Clinical Profile, Radiological Features, and Outcome. Stroke. 54(5). 1214–1223. 34 indexed citations

Jong, Cindy M.M. de, et al.. (2023). The Post–Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice. Seminars in Thrombosis and Hemostasis. 49(7). 764–773. 9 indexed citations

Ebinger, Martin, Erik Freitag, Peter Harmel, et al.. (2022). Follow-up of Patients With Stroke Based on Opt-out Choice. Neurology. 99(13). e1335–e1344. 3 indexed citations

Witsch, Jens, Bob Siegerink, Christian H. Nolte, et al.. (2021). Prognostication after intracerebral hemorrhage: a review. SHILAP Revista de lepidopterología. 3(1). 22–22. 39 indexed citations

Scheitz, Jan F., Leonie H. A. Broersen, Ramanan Ganeshan, et al.. (2021). High‐Sensitivity Cardiac Troponin T and Recurrent Vascular Events After First Ischemic Stroke. Journal of the American Heart Association. 10(10). e018326–e018326. 17 indexed citations

Goerling, Ute, et al.. (2021). What do people with lung cancer and stroke expect from patient navigation? A qualitative study in Germany. BMJ Open. 11(12). e050601–e050601. 6 indexed citations

Klok, Frederikus A., Gudula J.A.M. Boon, Stefano Barco, et al.. (2020). The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. European Respiratory Journal. 56(1). 2001494–2001494. 394 indexed citations breakdown →

10.

Kufner, Anna, et al.. (2020). Two simple and rapid methods based on maximum diameter accurately estimate large lesion volumes in acute stroke. Brain and Behavior. 10(11). e01828–e01828.

11.

Wieschowski, Susanne, Nico Riedel, Hannes Kahrass, et al.. (2019). Result dissemination from clinical trials conducted at German university medical centers was delayed and incomplete. Journal of Clinical Epidemiology. 115. 37–45. 29 indexed citations

12.

Toelch, Ulf, Ahmed A. Khalil, Ulrich Dirnagl, et al.. (2019). 2019 - Improving [Your] Science Course - Charité Universitätsmedizin Berlin. OSF Preprints (OSF Preprints).

13.

Klok, Frederikus A., Stefano Barco, & Bob Siegerink. (2019). Measuring functional limitations after venous thromboembolism: A call to action. Thrombosis Research. 178. 59–62. 35 indexed citations

14.

Piper, Sophie K., Ulrike Grittner, André Rex, et al.. (2019). Exact replication: Foundation of science or game of chance?. PLoS Biology. 17(4). e3000188–e3000188. 16 indexed citations

15.

Andersen, Lars W., Mathias J. Holmberg, Asger Granfeldt, et al.. (2018). Neighborhood characteristics, bystander automated external defibrillator use, and patient outcomes in public out-of-hospital cardiac arrest. Resuscitation. 126. 72–79. 32 indexed citations

16.

Siegerink, Bob, Alberto Maino, Ale Algra, & F.R. Rosendaal. (2015). Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women. Journal of Thrombosis and Haemostasis. 13(9). 1568–1575. 31 indexed citations

17.

Maino, Alberto, Bob Siegerink, Luca A. Lotta, et al.. (2015). Plasma ADAMTS‐13 levels and the risk of myocardial infarction: an individual patient data meta‐analysis. Journal of Thrombosis and Haemostasis. 13(8). 1396–1404. 49 indexed citations

18.

Siegerink, Bob, Renke Maas, Carla Y. Vossen, et al.. (2012). Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study. Clinical Research in Cardiology. 102(3). 193–202. 57 indexed citations

19.

Winckers, Kristien, Bob Siegerink, Connie Duckers, et al.. (2011). Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study. Journal of Thrombosis and Haemostasis. 9(11). 2243–2250. 21 indexed citations

20.

Siegerink, Bob, F.R. Rosendaal, & Ale Algra. (2008). Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. Journal of Thrombosis and Haemostasis. 7(3). 385–390. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact